Myxedema Coma In A Patient With Type 1 Neurofibromatosis: Rare Association [coma Mixedematoso Em Paciente Com Neurofibromatose Tipo 1: Associação Rara]

dc.creatorSasazawa D.T.
dc.creatorTsukumo D.M.
dc.creatorLalli C.A.
dc.date2013
dc.date2015-06-25T19:14:52Z
dc.date2015-11-26T14:57:46Z
dc.date2015-06-25T19:14:52Z
dc.date2015-11-26T14:57:46Z
dc.date.accessioned2018-03-28T22:09:33Z
dc.date.available2018-03-28T22:09:33Z
dc.identifier
dc.identifierArquivos Brasileiros De Endocrinologia E Metabologia. , v. 57, n. 9, p. 743 - 747, 2013.
dc.identifier42730
dc.identifier
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-84892386974&partnerID=40&md5=62109b4da7dc0dac7e0f00f701e8826a
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/89157
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/89157
dc.identifier2-s2.0-84892386974
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1255721
dc.descriptionMyxedema coma, a rare but fatal emergency, is an extreme expression of hypothyroidism. We describe a 51-year-old male patient who has discontinued hypothyroidism treatment 10 months earlier and developed lethargy, edema, and cold intolerance symptoms. He also had a previous diagnosis of neurofibromatosis. After admission, he progressed to respiratory insufficiency and coma. The prompt recognition of the condition, thyroid hormone replacement, and management of the complications (hypoventilation, cardiogenic shock associated with swinging heart, adrenal and renal insufficiency and sepsis), resulted in a favorable evolution.
dc.description57
dc.description9
dc.description743
dc.description747
dc.descriptionKwaku, M.P., Burman, K.D., Myxedema coma (2007) J Intensive Care Med, 22, pp. 224-231
dc.descriptionWartofsky, L., Myxedema coma (2000) The Thyroid: A Fundamental and Clinical Text, p. 843. , Braverman LE, Utiger RD (eds.). Philadelphia Lippincott: Williams & Wilkins
dc.descriptionDutta, P., Bhansali, A., Masoodi, S., Bhadada, S., Sharma, N., Rajput, R., Predictors of outcome in myxedema coma: A study from a tertiary care centre (2008) Critical Care, 12, pp. S1
dc.descriptionRodríguez, I., Fluiters, E., Pérez-Méndez, L.F., Luna, R., Páramo, C., García-Mayor, R.V., Factors associated with mortality of patients with myxoedema coma: Prospective study in 11 cases treated in a single institution (2004) J Endocrinol, 180, pp. 347-350
dc.descriptionKearney, T., Dang, C., Diabetic and endocrine emergencies (2007) Postgrad Med J, 83, pp. 79-86
dc.descriptionDanilovic, D.L.S., Almeida, M.Q., Neto, R.A.B., Martins, H., Coma Mixedematoso (2012) Emergências Clinicas Abordagem Prática, pp. 974-980. , 7th Ed. Barueri: Manole
dc.descriptionSantiago, R., Rashkin, M.C., Lithium toxicity and myxedema coma in an elderly woman (1990) J Emerg Med, 8, p. 63
dc.descriptionPark, C.W., Shin, Y.S., Ahn, S.J., Kim, S.Y., Choi, E.J., Chang, Y.S., Thyroxine treatment induces upregulation of renin-angiotensin-aldosterone system due to decreasing effective plasma volume in patients with primary myxoedema (2001) Nephrol Dial Transplant, 6, pp. 1799-1806
dc.descriptionKlubo-Gwieedzinska, J., Wartofsky, L., Thyroid emergencies (2012) Med Clin N Am, 96, pp. 385-403
dc.descriptionVillabona, C., Sahun, M., Roca, M., Mora, J., Gomez, N., Gomez, J.M., Blood volumes and renal function in overt and subclinical primary hypothyroidism (1999) Am J Med Sci, 318, p. 27280
dc.descriptionIwasaki, Y., Oiso, Y., Yamauchi, K., Osmoregulation of plasma vasopressin in myxedema (1990) J Clin Endocrinol Metab, 70, pp. 534-539
dc.descriptionBarker, D., Wright, E., Nguyen, K., Cannon, L., Fain, P., Goldgar, D., Gene for von Recklinghausen neurofbromatosis is in the pericentromeric region of chromosome 1 7 (1987) Science, 236, pp. 1100-1102
dc.descriptionAbbas, A., Lichtman, A.H., Disease caused by immune responses: Hipersensitivity and autoimmunity (2005) Cellular and Molecular Immunology, pp. 411-431. , Abbas A, Lichtman AH, eds., 5th ed. Philadelphia: Saunders
dc.descriptionYalcin, B., Tamer, E., Gür, G., Oztas, P., Polat, M.U., Alli, N., Neurofibroma-tosis 1/Noonan syndrome associated with Hashimoto's thyroidi-tis and vitiligo (2006) Acta Derm Venereol, 86, pp. 80-81
dc.descriptionNanda, A., Autoimmune diseases associated with neurofibromato-sis type 1 (2008) Ped Dermatology, 25 (3), pp. 392-393
dc.descriptionMackerrow, S.D., Osborn, L.A., Levy, H., Eaton, R.P., Economou, P., Myxedema-associated cardiogenic shock treated with intravenous triiodothyronine (1992) Ann Intern Med, 117, pp. 1014-1015
dc.languageen
dc.languagept
dc.publisher
dc.relationArquivos Brasileiros de Endocrinologia e Metabologia
dc.rightsaberto
dc.sourceScopus
dc.titleMyxedema Coma In A Patient With Type 1 Neurofibromatosis: Rare Association [coma Mixedematoso Em Paciente Com Neurofibromatose Tipo 1: Associação Rara]
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución